Location: Cleveland
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Cleveland
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
The PREDICT Registry:
Phase N/A · Cleveland Clinic Foundation-Taussig Cancer Inst · PreludeDx · NCT03448926A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants
Phase 3 · Cleveland Clinic Foundation · Hoffmann-La Roche · NCT06588855Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Phase 1 · Cleveland Clinic · Stelexis BioSciences · NCT06533761Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 · Univ Hosp Cleveland Med Ctr · Novo Nordisk A/S · NCT06612268A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · Seidman Cancer Center · New York Blood Center · NCT01656603Parent-Mediated Telehealth Intervention for Insomnia in Young Autistic Children
NA · Case Western Reserve University · Emory University · NCT07435740Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 3 · Cole Eye Institute-9500 Euclid Ave · IDEAYA Biosciences · NCT07015190Dextenza in the Post-op Management of Vitreoretinal Surgeries
Phase 4 · Cole Eye Institute, Cleveland Clinic · The Cleveland Clinic · NCT04371445Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Phase 3 · University Hospitals Cleveland Medical Center · GOG Foundation · NCT05659381A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · Cleveland Clinic Taussig Cancer Center Investigational Pharm · Pfizer · NCT05355701Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
NA · Ian J. Neeland, MD · NCT07244445Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · UH Rainbow Babies and Children's Hospital (University Hospit · Fred Hutchinson Cancer Center · NCT03779854A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Phase 2 · Case Comprehensive Cancer Center, Cleveland Clinic Foundatio · Case Comprehensive Cancer Center · NCT07003542ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
NA · The Cleveland Clinic Foundation · JenaValve Technology, Inc. · NCT06608823Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
Phase N/A · Cleveland Clinic Foundation · The Cleveland Clinic · NCT00921986Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05987241Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Phase 3 · The Cleveland Clinic Foundation · NX Development Corp · NCT05804370Infant Formula in Infants and Children With Cow's Milk Allergy
NA · Cleveland Clinic · Abbott Nutrition · NCT06456541Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Phase 2/Phase 3 · UH Rainbow Babies & Children's Hospital · Yale University · NCT04924322Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Gilead Sciences · NCT05633654JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Phase 2 · University Hospitals Cleveland Medical Center · PPD Development, LP · NCT06701656A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · University Hospitals Cleveland Medical Center · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Phase N/A · Cleveland Clinic Foundation · The Cleveland Clinic · NCT04088370MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · University Hospitals Cleveland Medical Center · Stryker Instruments · NCT03072927RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Th
Phase N/A · Case Western Reserve University · Boston Scientific Corporation · NCT01719055Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Particip
Phase 1/Phase 2 · University Hospitals Cleveland Medical Center ( Site 0043) · Merck Sharp & Dohme LLC · NCT06353386Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors
Phase N/A · Case Comprehensive Cancer Center, UH Rainbow Babies & Childr · Case Comprehensive Cancer Center · NCT07114614A Study of ASP1002 in Adults for Treatment of Solid Tumors
Phase 1 · University Hospitals of Cleveland · Astellas Pharma Global Development, Inc. · NCT05719558
Look up another city
Look up another condition